Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Klotho Protects Diabetic Nephropathy via Regulating Podocyte Ca2+-Permeable Channels
저자 Seung-Kuy Cha
출판정보 2023; 2023(1):
키워드
초록 Klotho is an anti-aging protein predominantly produced in the kidney that protects the kidney filter and renal diseases via regulating renal Ca2+ ion channels. Intracellular Ca2+ homeostasis in podocytes is vital for maintaining proper filter function, and the deregulation of Ca2+ signaling via TRPC5 or 6 channels has been implicated in proteinuria in diabetic nephropathy (DN). Recently, we reported that exaggerated Orai1-mediated store-operated Ca2+ entry in a hyperinsulinemic early period of DN causes proteinuria, while TRPC5 and 6 channels were increased in the late period of DN leading to proteinuria. However, it is still unknown whether and how Klotho integrates multiple podocyte Ca2+ channels to protect DN. This lecture will provide current research progress of Klotho and Ca2+ signaling targeting DN and suggest future direction. Briefly, in the progression of DN, Klotho has been reduced along with podocyte markers, while Orai1 and TRPC5/6 were overexpressed in early and late periods in DN mice, respectively. Administration of Klotho protein ameliorated podocyte foot process disruption and proteinuria in DN mice. Klotho suppressed Orai1- and TRPC5/6-mediated Ca2+ entry in mouse-cultured podocytes via inhibiting growth factor-driven channel activation. Mechanistically, Klotho acutely reduced cell surface abundance of channels by suppressing their phosphoinositide-3-kinase-dependent trafficking. Functionally, actin remodeling driven by Orai1 and TRPC6 overactivation was ameliorated by Klotho. These findings propose that Klotho ameliorates podocyte injury by stabilizing Orai1 and TRPC5/6 channels-mediated Ca2+ signaling to prevent DN. This lecture reveals an underlying mechanism by which Klotho protects proteinuria and podocytopathy through stabilizing Ca2+ signaling mediated by Orai1 and TRPC5/6, and offers a new potential therapeutic strategy for the treatment of DN.
원문(PDF) PDF 원문보기
위로가기